Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology

In the past decades, new cancer treatments have been introduced in pediatric oncology leading to improvement in clinical outcomes and survival rates. However, due to inter-individual differences, some children experience severe chemotherapy-induced toxicities or a poor clinical outcome. An explanati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernsen, Emma C., Hagleitner, Melanie M., Kouwenberg, Theodorus W., Hanff, Lidwien M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421781/
https://www.ncbi.nlm.nih.gov/pubmed/32848787
http://dx.doi.org/10.3389/fphar.2020.01184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421781/
https://www.ncbi.nlm.nih.gov/pubmed/32848787
http://dx.doi.org/10.3389/fphar.2020.01184

Ejemplares similares